Michael Cameron, MD, FAAD

Cover Story

JAK Inhibitor Safety: What Did ORAL Surveillance Really Teach Us?

03/07/2023

The goal of this article is not to minimize safety concerns, but rather to promote a more nuanced and contextualized conversation on the appropriate use of Janus kinase inhibitors in dermatology.

The goal of this article is not...

03/07/2023

The Dermatologist

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

March 17 ⁠–⁠ March 19

March 27 ⁠–⁠ March 30

See Full Calendar

Michael Cameron, MD, FAAD

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products